# VIP Enrichment Batch 1: Readiness Assessment

## 1. Readiness Goal
To determine if the Vilo Intelligence Platform (VIP) has sufficient cross-therapeutic breadth to serve as the governed memory layer for a production clinical operations engine.

## 2. Assessment Criteria

| Criterion | Status | Validation Evidence |
|-----------|--------|---------------------|
| **New infectious disease patterns captured?** | PASS | Symptom tracking, Swabs, Fever diaries abstracted. |
| **Timed collection/sample handling patterns captured?** | PASS | Biospecimen Chain-of-Custody and <48h inclusion windows added. |
| **Household contact patterns captured?** | PASS | Index vs Contact linkage explicitly mapped as Source Blueprint requirements. |
| **No raw protocol text stored?** | PASS | All patterns passed the `validatePatternSanitization` guardrail. |
| **All patterns remain CANDIDATE?** | PASS | Database seed verified: `approval_status: "CANDIDATE"` across all 22 entries. |
| **Reuse requires coordinator acceptance?** | PASS | Hardcoded boolean `coordinator_acceptance: false` on all new entries. |

## 3. Final Determination

**VIP Cross-Therapeutic Memory: `READY`**

**Conclusion:**
VIP has successfully demonstrated the capacity to digest radically different therapeutic structures (Chronic Pain vs Acute Virology) and distill them into universally structured software constraints (Hard Stops, Deviation Risks, Source Blueprints). The architecture is ready for a multi-specialty production deployment.
